hexamethonium has been researched along with Gastritis in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TRUSOV, VV | 2 |
2 other studies available for hexamethonium and Gastritis
| Article | Year |
|---|---|
[Effect of the ganglion-blocking preparation hexonium on the functional state of the stomach in patients with peptic ulcer and chronic gastritis].
Topics: Autonomic Agents; Gastritis; Hexamethonium; Humans; Peptic Ulcer | 1962 |
[Results of Hexonium and Gangleron therapy of patients with peptic ulcer and chronic gastritis].
Topics: Bis-Trimethylammonium Compounds; Ganglionic Blockers; Gastritis; Hexamethonium; Humans; Peptic Ulcer | 1962 |